ZNF547
gene geneOn this page
Also known as FLJ31100
Summary
ZNF547 (zinc finger protein 547, HGNC:26432) is a protein-coding gene on chromosome 19q13.43, encoding Zinc finger protein 547 (Q8IVP9). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 284306 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 65 total
- MANE Select transcript:
NM_173631
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26432 |
| Approved symbol | ZNF547 |
| Name | zinc finger protein 547 |
| Location | 19q13.43 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ31100 |
| Ensembl gene | ENSG00000152433 |
| Ensembl biotype | protein_coding |
| Entrez | 284306 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000282282, ENST00000595335, ENST00000597567, ENST00000599604, ENST00000879319
RefSeq mRNA: 1 — MANE Select: NM_173631
NM_173631
CCDS: CCDS33131
Canonical transcript exons
ENST00000282282 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001005190 | 57377128 | 57379565 |
| ENSE00003516121 | 57371782 | 57371908 |
| ENSE00003619128 | 57368544 | 57368579 |
| ENSE00003671371 | 57363551 | 57363703 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 86.30.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.6705 / max 113.8635, expressed in 1801 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177769 | 18.6705 | 1801 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.15 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 79.47 | gold quality |
| cerebellar cortex | UBERON:0002129 | 79.32 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 78.82 | gold quality |
| cerebellum | UBERON:0002037 | 77.54 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.09 | gold quality |
| embryo | UBERON:0000922 | 75.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 75.56 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 74.88 | gold quality |
| muscle of leg | UBERON:0001383 | 74.73 | gold quality |
| gastrocnemius | UBERON:0001388 | 74.68 | gold quality |
| right adrenal gland | UBERON:0001233 | 74.59 | gold quality |
| left adrenal gland | UBERON:0001234 | 74.41 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 74.41 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.35 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 73.85 | gold quality |
| right frontal lobe | UBERON:0002810 | 73.62 | gold quality |
| adenohypophysis | UBERON:0002196 | 73.52 | gold quality |
| ventricular zone | UBERON:0003053 | 72.85 | gold quality |
| adrenal gland | UBERON:0002369 | 72.59 | gold quality |
| cortical plate | UBERON:0005343 | 72.42 | gold quality |
| adrenal cortex | UBERON:0001235 | 72.12 | gold quality |
| right uterine tube | UBERON:0001302 | 72.04 | gold quality |
| apex of heart | UBERON:0002098 | 71.95 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.93 | gold quality |
| spleen | UBERON:0002106 | 71.78 | gold quality |
| pituitary gland | UBERON:0000007 | 71.51 | gold quality |
| right atrium auricular region | UBERON:0006631 | 71.51 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.38 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.22 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2334.1 | ZNF547 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:28273063
miRNA regulators (miRDB)
82 targeting ZNF547, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-613 | 99.91 | 71.50 | 1710 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-153-5P | 99.89 | 73.86 | 6317 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-369-3P | 99.85 | 70.52 | 2264 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
Cross-species orthologs
0 orthologs
Paralogs (51): WIZ (ENSG00000011451), ZNF416 (ENSG00000083817), MYNN (ENSG00000085274), PRDM4 (ENSG00000110851), PRDM2 (ENSG00000116731), ZBTB17 (ENSG00000116809), ZNF644 (ENSG00000122482), GZF1 (ENSG00000125812), ZNF426 (ENSG00000130818), ZNF287 (ENSG00000141040), ZNF697 (ENSG00000143067), ZNF687 (ENSG00000143373), ZNF214 (ENSG00000149050), ZNF776 (ENSG00000152443), ZNF230 (ENSG00000159882), ZNF222 (ENSG00000159885), ZNF233 (ENSG00000159915), ZNF333 (ENSG00000160961), ZNF319 (ENSG00000166188), ZNF592 (ENSG00000166716), ZNF646 (ENSG00000167395), ZNF507 (ENSG00000168813), ZNF768 (ENSG00000169957), ZNF417 (ENSG00000173480), ZNF408 (ENSG00000175213), ZBTB41 (ENSG00000177888), ZNF223 (ENSG00000178386), ZNF852 (ENSG00000178917), ZNF784 (ENSG00000179922), ZNF572 (ENSG00000180938), ZNF707 (ENSG00000181135), ZNF746 (ENSG00000181220), ZNF467 (ENSG00000181444), ZNF530 (ENSG00000183647), ZNF17 (ENSG00000186272), ZNF527 (ENSG00000189164), ZKSCAN7 (ENSG00000196345), ZNF34 (ENSG00000196378), ZNF774 (ENSG00000196391), ZNF777 (ENSG00000196453)
Protein
Protein identifiers
Zinc finger protein 547 — Q8IVP9 (reviewed: Q8IVP9)
All UniProt accessions (4): Q8IVP9, M0QX63, M0QYW2, M0QZZ8
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8IVP9-1 | 1 | yes |
| Q8IVP9-2 | 2 |
RefSeq proteins (1): NP_775902* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13465
UniProt features (14 total): zinc finger region 10, splice variant 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IVP9-F1 | 69.66 | 0.18 |
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
| R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins |
MSigDB gene sets: 52 (showing top):
WTGAAAT_UNKNOWN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, PPARA_01, YY1_01, TGGAAA_NFAT_Q4_01, TCANNTGAY_SREBP1_01, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, BANP_TARGET_GENES, CEBPZ_TARGET_GENES, HES2_TARGET_GENES, NCOA6_TARGET_GENES, ZFP91_TARGET_GENES, ZNF322_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), double-stranded DNA binding (GO:0003690), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
| Regulation of endogenous retroelements | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| DNA binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
134 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF547 | MVK | Q03426 | 64 |
| ZNF547 | NME8 | Q8N427 | 62 |
| ZNF547 | SPAG17 | Q6Q759 | 60 |
| ZNF547 | MED14 | O60244 | 57 |
| ZNF547 | LRGUK | Q96M69 | 47 |
| ZNF547 | TUT1 | Q9H6E5 | 45 |
| ZNF547 | MRPS34 | P82930 | 42 |
| ZNF547 | NME3 | Q13232 | 42 |
| ZNF547 | NME4 | O00746 | 42 |
| ZNF547 | NME5 | P56597 | 42 |
| ZNF547 | NME6 | O75414 | 42 |
| ZNF547 | NME1 | P15531 | 42 |
| ZNF547 | NME2 | P22392 | 42 |
| ZNF547 | Q32Q12 | Q32Q12 | 42 |
| ZNF547 | NME7 | Q9Y5B8 | 42 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF250 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | PCSK5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | GPATCH2L | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | MAGOHB | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | ZNF587 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | SCNM1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | MAPRE3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF547 | ARPC4-TTLL3 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF250 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF330 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PCSK5 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GPATCH2L | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAGOHB | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF417 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| SCNM1 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF587 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MAPRE3 | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
| POLR1C | ZNF547 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (16): ZNF547 (Two-hybrid), ZNF547 (Two-hybrid), ZNF547 (Two-hybrid), ZNF547 (Two-hybrid), ZNF547 (Two-hybrid), SCNM1 (Two-hybrid), POLR1C (Two-hybrid), ZNF417 (Two-hybrid), ZNF250 (Two-hybrid), ZNF587 (Two-hybrid), ZYG11A (Affinity Capture-MS), SART3 (Affinity Capture-MS), TUT1 (Affinity Capture-MS), CDCA4 (Affinity Capture-MS), ARPC4-TTLL3 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A3KN32, B2RUI1, O43296, O75123, P10072, P17020, P17097, P51814, P52736, P52740, Q07230, Q08ER8, Q13398, Q14590, Q32KN0, Q3KQV3, Q3MIS6, Q4V8A8, Q5CZA5, Q5RBQ3, Q5RBX0, Q5RCD9, Q5RCX4, Q6GQR8, Q6NX45, Q6P9A3, Q6PK81, Q7TSH9, Q7TSI0, Q7Z7L9, Q86UD4, Q8BFS8, Q8BLB0, Q8IVP9, Q8IZ26, Q8N9F8
Diamond homologs: A2RRD8, A6NFI3, A6NM28, A8MUZ8, A8MWA4, B2RUI1, B4DU55, E9Q8G5, O43296, O43361, O75467, O75820, P0CH99, P0CI00, P10078, P16373, P16374, P17021, P17023, P17032, P17097, P17098, P21506, P51786, P52740, Q06732, Q08ER8, Q13106, Q13360, Q13398, Q14592, Q147U1, Q32M78, Q3KQV3, Q3MIS6, Q3SY52, Q571J5, Q5CZA5, Q5HY98, Q5R7I8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 56 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
732 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:57364799:C:A | acceptor_gain | 1.0000 |
| 19:57371780:AG:A | acceptor_gain | 1.0000 |
| 19:57371781:GG:G | acceptor_gain | 1.0000 |
| 19:57371906:TAGG:T | donor_loss | 1.0000 |
| 19:57371906:TAGGT:T | donor_loss | 1.0000 |
| 19:57371907:AGG:A | donor_loss | 1.0000 |
| 19:57371909:G:A | donor_loss | 1.0000 |
| 19:57371909:GTAAG:G | donor_loss | 1.0000 |
| 19:57371910:T:A | donor_loss | 1.0000 |
| 19:57363700:CGAGG:C | donor_loss | 0.9900 |
| 19:57363701:GAGGT:G | donor_loss | 0.9900 |
| 19:57363702:AGGT:A | donor_loss | 0.9900 |
| 19:57363703:GGTG:G | donor_loss | 0.9900 |
| 19:57363704:G:GA | donor_loss | 0.9900 |
| 19:57363705:T:A | donor_loss | 0.9900 |
| 19:57368542:AG:A | acceptor_gain | 0.9900 |
| 19:57368543:GG:G | acceptor_gain | 0.9900 |
| 19:57368576:ACAG:A | donor_loss | 0.9900 |
| 19:57368580:G:T | donor_loss | 0.9900 |
| 19:57368581:T:A | donor_loss | 0.9900 |
| 19:57371776:T:TA | acceptor_gain | 0.9900 |
| 19:57371777:G:A | acceptor_gain | 0.9900 |
| 19:57371777:GGCA:G | acceptor_loss | 0.9900 |
| 19:57371778:GCAG:G | acceptor_loss | 0.9900 |
| 19:57371779:CAG:C | acceptor_loss | 0.9900 |
| 19:57371780:A:AG | acceptor_gain | 0.9900 |
| 19:57371780:A:G | acceptor_loss | 0.9900 |
| 19:57371781:G:GC | acceptor_loss | 0.9900 |
| 19:57371781:G:GG | acceptor_gain | 0.9900 |
| 19:57371781:GGGT:G | acceptor_gain | 0.9900 |
AlphaMissense
2685 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:57377637:T:C | F221L | 0.993 |
| 19:57377639:T:A | F221L | 0.993 |
| 19:57377639:T:G | F221L | 0.993 |
| 19:57378057:T:C | F361L | 0.993 |
| 19:57378059:C:A | F361L | 0.993 |
| 19:57378059:C:G | F361L | 0.993 |
| 19:57378002:C:A | H342Q | 0.986 |
| 19:57378002:C:G | H342Q | 0.986 |
| 19:57377721:T:C | F249L | 0.985 |
| 19:57377723:T:A | F249L | 0.985 |
| 19:57377723:T:G | F249L | 0.985 |
| 19:57377973:T:C | F333L | 0.985 |
| 19:57377975:C:A | F333L | 0.985 |
| 19:57377975:C:G | F333L | 0.985 |
| 19:57378004:A:C | Q343P | 0.985 |
| 19:57378000:C:G | H342D | 0.984 |
| 19:57377918:T:A | H314Q | 0.983 |
| 19:57377918:T:G | H314Q | 0.983 |
| 19:57378076:T:C | L367P | 0.983 |
| 19:57377916:C:G | H314D | 0.982 |
| 19:57377992:T:C | L339P | 0.982 |
| 19:57377656:T:C | L227P | 0.978 |
| 19:57377750:T:A | H258Q | 0.978 |
| 19:57377750:T:G | H258Q | 0.978 |
| 19:57377469:T:C | F165L | 0.977 |
| 19:57377471:T:A | F165L | 0.977 |
| 19:57377471:T:G | F165L | 0.977 |
| 19:57377638:T:C | F221S | 0.977 |
| 19:57377553:T:C | F193L | 0.975 |
| 19:57377555:T:A | F193L | 0.975 |
dbSNP variants (sampled 300 via entrez): RS1000249014 (19:57366030 A>C,T), RS1000614090 (19:57370850 C>T), RS1000630374 (19:57376728 A>T), RS1000872006 (19:57362631 A>T), RS1001179812 (19:57376652 T>C,G), RS1001210762 (19:57371485 A>T), RS1001283863 (19:57367950 C>G), RS1001557706 (19:57379947 G>T), RS1002040111 (19:57375990 C>T), RS1002064148 (19:57369962 G>A), RS1002242746 (19:57361838 T>A), RS1002445384 (19:57375323 C>G), RS1002588813 (19:57375438 G>A), RS1002656664 (19:57379729 G>A,C), RS1002763452 (19:57373893 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010923_9 | Beta blocker survival benefit in heart failure with reduced ejection fraction (time to all cause mortality x beta blocker interaction) | 6.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004352 | mortality |
| EFO:0007766 | response to beta blocker |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
31 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| propionaldehyde | increases expression | 1 |
| titanium dioxide | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | increases expression, affects cotreatment | 1 |
| abrine | increases expression | 1 |
| dorsomorphin | affects cotreatment, increases expression | 1 |
| licochalcone B | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, increases expression | 1 |
| Phthalic Acids | increases methylation | 1 |
| Rotenone | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Sodium Dodecyl Sulfate | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | affects expression | 1 |
| Acrylamide | increases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_HD27 | HEK293 eGFP-ZNF547 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.